CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.
about
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibSuppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer.Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expressionSynthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivoA New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth.TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ.Chm-1 gene-modified bone marrow mesenchymal stem cells maintain the chondrogenic phenotype of tissue-engineered cartilage.Effect of C7-substitution of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines on the selectivity towards a subclass of histone deacetylases.NPC-16, a novel naphthalimide-polyamine conjugate, induced apoptosis and autophagy in human hepatoma HepG2 cells and Bel-7402 cells.Effect of DNA damage response by quinazolinone analogue HMJ-38 on human umbilical vein endothelial cells: evidence for γH2A.X and DNA-PK-dependent pathway.
P2860
Q33654186-90842975-415C-4D44-BFCF-0B5C32A3C58AQ33843839-2F51EF4F-3274-450E-B657-1B05F9B24C16Q34297762-6CD6EEC6-9633-4EF9-AF29-253FBBC10694Q34362364-21C39A88-B276-4231-99A3-AF0B5C087F75Q35038107-91972D7C-F9B6-45C7-8F08-4CE4949B8F94Q35531332-28128067-9A8C-4E5E-909C-3A9198A9DFDAQ36071985-5B6AB84C-6976-4B86-AA94-D08EE9E0CFEFQ36875895-84C10442-76EC-40E0-90C6-A688E49C7FB8Q38951103-F49535A6-9BE3-4861-B538-CC8C14C39E75Q39661072-22534574-674F-4CD7-8201-55D09CDACF52Q46990782-92F0AA86-83DE-4105-A241-63152F3B514C
P2860
CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CHM-1, a new vascular targetin ...... eath receptor 5 up-regulation.
@ast
CHM-1, a new vascular targetin ...... eath receptor 5 up-regulation.
@en
type
label
CHM-1, a new vascular targetin ...... eath receptor 5 up-regulation.
@ast
CHM-1, a new vascular targetin ...... eath receptor 5 up-regulation.
@en
prefLabel
CHM-1, a new vascular targetin ...... eath receptor 5 up-regulation.
@ast
CHM-1, a new vascular targetin ...... eath receptor 5 up-regulation.
@en
P2093
P2860
P356
P1476
CHM-1, a new vascular targetin ...... death receptor 5 up-regulation
@en
P2093
An-Chi Tsai
Chieh-Yu Peng
Chih-Ya Wang
Hui-Lung Sun
Kuo-Hsiung Lee
Sheng-Chu Kuo
Shih-Wei Wang
Shiow-Lin Pan
Ya-Ling Chang
P2860
P304
P356
10.1074/JBC.M109.036277
P407
P577
2009-12-11T00:00:00Z